Gracure Pharmaceuticals Ltd.

Gracure Pharmaceuticals is engaged in R&D and manufacturing of finished dosage forms, operating two facilities producing tablets, capsules, syrups/suspensions and non-sterile ointments. With globally accepted approvals including EU-GMP, TGA Australia and WHO-GMP, the company has delivered products to more than 25 countries including Belgium, Canada, Australia, the UK, Vietnam, Germany, the Philippines, Malaysia and Peru, supported by a DSIR-approved R&D center with dedicated scientists.